We suggest that in future studies, it would be interesting to analyze the serum levels of syndecan-1 together with interleukins such as TNF-α, IL-17, or IL-8, among other markers of inflammation, for the purpose of differentiating RA in the early stages from long-lasting RA. Here, IL17A is linked to rheumatoid arthritis.